AHN Cancer Institute Recruit Brings Unique Expertise in Benefits of Exercise and Nutrition for Improving Cancer Treatment Outcomes
Colin Champ, MD, to lead AHN exercise oncology program at AGH Suburban Campus in Bellevue.
AHN Earns Prestigious Three-Star Rating for Lung Cancer Resection Surgery from The Society of Thoracic Surgeons
Allegheny Health Network’s Allegheny General and Forbes hospitals have earned distinguished three-star ratings from The Society of Thoracic Surgeons General Thoracic Surgery Database for their lung cancer resection surgery program.
AHN Cancer Institute, Illumina to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care
Allegheny Health Network Cancer Institute and Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced a collaboration to evaluate the impact of in-house comprehensive genomic profiling to enhance patient care.
Prominent Local Cancer Surgeon Rebecca Edmonds, MD, Joins AHN
Rebecca D. Edmonds, MD, a surgical oncologist specializing in the treatment of diseases of the liver, pancreas, gallbladder, spleen, colon, thyroid and breast, has joined the Allegheny Health Network Cancer Institute.
AHN Engineers Immune Cells
Clinicians at the AHN Cancer Institute are taking a giant leap forward in CAR T-cell therapy.
Accredited Program Makes Young Man’s CRC a Distant Memory
Trevor Batey was enjoying the first years of marriage and his work as a truck driver when cancer put the brakes on his life. He was in his early 20s when he saw blood in his stool, had a colonoscopy, and was diagnosed with colorectal cancer.
Decoding Genes to Target Cancer
Allegheny Health Network announced its new Center for Genetics and Precision Medicine, which will provide highly personalized and precise medicine by uncovering patients’ DNA changes within cancer cells to determine effective treatments.
PD-1 Inhibitor Combinations, Alternative Therapeutic Approaches Are Moving the Needle in NSCLC
Better Understanding of Biomarkers Can Inform Immunotherapy Treatment in SCLC
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
2 Clarke Drive Cranbury, NJ 08512